A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED MULTICENTER PHASE 2 DOSE-RANGING STUDY TO ASSESS THE SAFETY AND EFFICACY OF MULTIPLE VAY736 DOSES ADMINISTERED SUBCUTANEOUSLY IN PATIENTS WITH MODERATE TO SEVERE PRIMARY SJOGREN'S SYNDROME
Principal Investigator(s)
Escalante, Agustin
Funded by
NOVARTIS PHARMACEUTICALS CORPORATION
Research Start Date
Status
Active